Insider · CIK 0002036234

de Verneuil Vanina

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0002036234

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-25	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−13.7K sh	$9.82	−$135K	112,982
2026-02-24	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−3,117 sh	$9.53	−$29.7K	126,682
2026-02-23	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−4,445 sh	$7.45	−$33.1K	129,799
2026-02-22	VIRVir Biotechnology, Inc.A Award	EVP, General Counsel, Corp Sec	AAward	+55K sh	—	—	134,244
2026-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP, General Counsel, Corp Sec	AAward	+110K sh	—	—	110,000
2025-11-05	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−2,385 sh	$5.16	−$12.3K	78,210
2025-11-03	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−1,365 sh	$5.86	−$8,002.995	80,595
2025-02-26	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−7,373 sh	$9.14	−$67.4K	79,460
2025-02-24	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−5,140 sh	$9.45	−$48.6K	86,833
2025-02-22	VIRVir Biotechnology, Inc.A Award	EVP, General Counsel, Corp Sec	AAward	+35K sh	—	—	91,973
2025-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP, General Counsel, Corp Sec	AAward	+70K sh	—	—	70,000
2024-12-02	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−76 sh	$8.22	−$624.728	56,973
2024-11-06	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−4,397 sh	$10.11	−$44.5K	56,973
2024-11-05	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−2,347 sh	$9.47	−$22.2K	61,370
2024-11-01	VIRVir Biotechnology, Inc.S Sale	EVP, General Counsel, Corp Sec	SSale	−1,403 sh	$7.20	−$10.1K	63,717

Recent filings

Accepted (ET)
Feb 264
de Verneuil Vanina0001628280-26-012393
SEC(opens sec.gov)
Feb 244
de Verneuil Vanina0001628280-26-011328
SEC(opens sec.gov)
Nov 74
de Verneuil Vanina0001628280-25-050592
SEC(opens sec.gov)
Nov 44
de Verneuil Vanina0001628280-25-049159
SEC(opens sec.gov)
Feb 274
de Verneuil Vanina0001628280-25-008499
SEC(opens sec.gov)
Feb 254
de Verneuil Vanina0001628280-25-007690
SEC(opens sec.gov)
Dec 44
de Verneuil Vanina0001628280-24-049897
SEC(opens sec.gov)
Nov 74
de Verneuil Vanina0001628280-24-046462
SEC(opens sec.gov)
Nov 54
de Verneuil Vanina0001628280-24-045387
SEC(opens sec.gov)

Companies

Vir Biotechnology, Inc.EVP, General Counsel, Corp SecVIR

Address

C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900

SAN FRANCISCO, CA, 94158